Can a digital hub keep mentally ill patients healthy at home?
NCT ID NCT05160701
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests a telehealth system called Medherent for people with serious mental illness living in the community. The system dispenses medication, monitors health data like blood pressure and blood sugar, and allows virtual doctor visits. Researchers will track whether this approach reduces hospital visits and improves health outcomes in 300 participants.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Medherent telehealth platform with Bluetooth devices and virtual visits
What this could lead to
If successful, this could offer a practical way to improve medication adherence and health outcomes for people with serious mental illness living in the community.
What could go wrong
This is an early-stage study with 300 participants, and results may not apply broadly. The intervention relies on technology access and user engagement, which could limit effectiveness.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MENTAL DISORDERS, SEVERE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University of Maryland
Baltimore, Maryland, 20201, United States